Analystreport

Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Rexahn Pharmaceuticals, Inc.  (REXN) 
Last rexahn pharmaceuticals, inc. earnings: 8/7 06:30 am Check Earnings Report